One in 12 diabetics over age 40 has vision-threatening eye disease

April 12, 2004

CHICAGO - Pooled data from previous studies suggests that approximately 4.1 million U.S. adults 40 years or older have diabetic retinopathy (DR), a disorder of the retina that occurs as a complication of diabetes mellitus (DM), affecting one twelfth of diabetics in this age group, according to an article in the April issue of The Archives of Ophthalmology, a theme issue on blindness, and one of the JAMA/Archives journals.

According to the article, diabetic retinopathy is one of the leading causes of blindness in the United States. It affects the blood vessels in the retina, the light-sensitive layer of cells at the back of the eye. Retinopathy occurs in most people with long-standing DM but its incidence can be reduced with aggressive control of glucose levels and blood pressure, the article states.

John H. Kempen, M.D., Ph.D., of the Wilmer Eye Institute at The Johns Hopkins Medical Institutions, Baltimore, and colleagues in the Eye Diseases Prevalence Research Group, determined the prevalence of diabetic retinopathy among adults 40 years and older in the United States.

The researchers pooled data from eight population-based eye surveys. U.S. prevalence rates were estimated by using prevalence rates for DM reported in the 1999 National Health Interview Study, and 2000 U.S. Census population data.

The researchers found that among an estimated 10.2 million U.S. adults 40 years and older with DM, the estimated prevalence rates for retinopathy and vision threatening retinopathy were 40.3 percent and 8.2 percent, respectively. The estimated prevalence rates for retinopathy and vision-threatening retinopathy among the general U.S. population were 3.4 percent (4.1 million people) and 0.75 percent (899,000 people), respectively.

"The results of our pooled analysis indicate that diabetic retinopathy affects approximately two fifths of persons 40 years and older who identify themselves as having DM," the researchers write. "An estimated one twelfth of persons with DM in this age group have reached the stage of vision-threatening disease. Even though diabetic retinopathy is a disease occurring only among persons with DM, the prevalence of DM in the general population is high enough that diabetic retinopathy is highly prevalent in the general U.S. adult population."
-end-
(Arch Ophthalmol. 2004;122:552-563. Available post-embargo at archophthalmol.com)

Editor's Note: The Eye Diseases Prevalence Research Group is an initiative sponsored by the National Eye Institute of the National Institutes of Health (Bethesda, Md.) with additional funding from Prevent Blindness America (Schaumburg, Ill.) that seeks to estimate the prevalence rates for major eye disorders.

For more information, contact JAMA/Archives Media Relations at 312-464-JAMA (5262) or e-mail mediarelations@jama-archives.org .
To contact John H. Kempen, M.D., Ph.D., call John Lazarou at 410-502-8902.

The JAMA Network Journals

Related Blindness Articles from Brightsurf:

New eye drops may prevent a common cause of blindness
New eye drops could prevent vision loss after retinal vein occlusion, a major cause of blindness for millions of adults, a study by Columbia University researchers has found.

Scientists pinpoint brain coordinates for face blindness
Danish and Norwegian researchers have moved one step closer to understanding where face blindness stems from in the brain.

Protein closely linked to commonest cause of blindness
An international team of scientists has identified a protein which is strongly linked to the commonest cause of blindness in developed countries when its levels are raised in the blood.

New glaucoma test to help prevent blindness
Researchers have identified 107 genes that increase a person's risk of developing the eye disease glaucoma, and now developed a genetic test to detect those at risk of going blind from it.

Treatments for leading cause of blindness generate $0.9 to $3 billion
A new economic study, published in JAMA Ophthalmology and conducted by USC researchers at the Schaeffer Center for Health Policy & Economics, the Ginsburg Institute for Biomedical Therapeutics, and the Roski Eye Institute, quantifies the benefits of treatment for wAMD.

Identifying a gene for canine night blindness
An international team of researchers led by the University of Pennsylvania's Keiko Miyadera has identified the gene mutation responsible for a form of night blindness in dogs.

Poor diet can lead to blindness
An extreme case of 'fussy' or 'picky' eating caused a young patient's blindness, according to a new case report published today [2 Sep 2019] in Annals of Internal Medicine.

Brighter possibilities for treating blindness
Advances in preclinical research are now being translated into innovative clinical solutions for blindness, a review published in the 10th anniversary series of science Translational Medicine depicts.

How blindness shapes sound processing
Adults who lost their vision at an early age have more refined auditory cortex responses to simple sounds than sighted individuals, according to new neuroimaging research published in JNeurosci.

Study identifies new genes associated with the leading cause of blindness
A new study, published in Clinical Epigenetics, identifies genes associated with Age-related Macular Degeneration (AMD) that could represent new targets for future drug development.

Read More: Blindness News and Blindness Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.